Home 2020


U.S. FDA approves pancreatic cancer treatment shown to double patient lifespans

The drug Lynparza was developed by AstraZeneca and Merck as a maintenance treatment for patients with a specific gene mutation whose cancer spread beyond the pancreas.

U.S. FDA approves first ever treatment for postpartum depression

The newly-approved drug, sold under the brand name Zulresso, was shown to relieve depressive symptoms within hours of being administered in three different clinical trials €“ and it continued to show success throughout their 30-day followups.

United States FDA approves form of ketamine for depression treatment

Esketamine is the first new drug treatment approved for depression in decades. Current drugs target the feel-good brain chemical serotonin, and can take weeks or months to kick in. Ketamine targets a chemical called glutamate that is thought to restore brain connections that help relieve depression.

United States’ FDA approves world’s first device that could save thousands of premature infants from common heart condition

The Amplatzer Piccolo, a device even smaller than a small pea, now offers hope to premature infants and newborns who need corrective treatment, and who may be non-responsive to medical management and high risk to undergo corrective surgery.